Treatment of trochanteric fractures with the PFNA (proximal femoral nail antirotation) nail system - report of early results

Currently, intramedullary devices are widely used for the treatment of trochanteric femoral fractures. A new device designed by AO/ASIF, the PFNA (proximal femoral nail antirotation), represents a unique intramedullary nail system for improved management, particularly in the elderly. The aim of the present study was to analyze the results of treatment with PFNA in 50 patients with trochanteric fractures. The operating time, intraoperative blood loss, and intraoperative and postoperative complications were recorded. The length of the surgical procedure averaged 20.3 min, and intraoperative blood loss averaged 22.8 mL. Reoperation was necessary in two patients (4%). We conclude that the PFNA nail is as effective as other implants in the treatment of trochanteric fractures.